IDEAYA Biosciences, Inc. SEC filings IDYA

IDEAYA Biosciences, Inc. has 506 filings in SEC EDGAR's recent list, going back to Aug 26, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

IDEAYA Biosciences, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 3, 2026 —
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Shareholder vote results, Other events
Jun 23, 2026 Jun 16, 2026
8-K Current report
Other events
Jun 10, 2026 Jun 8, 2026
424B5 Prospectus supplement Jun 9, 2026 —
424B5 Prospectus supplement Jun 8, 2026 —
8-K Current report
Other events
Jun 3, 2026 Jun 3, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 1, 2026 Jun 1, 2026
8-K Current report
Other events
May 5, 2026 May 5, 2026
424B5 Prospectus supplement May 5, 2026 —
S-3ASR Automatic shelf registration May 5, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 16, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
8-K Current report
Other events
Apr 9, 2026 Apr 8, 2026
S-8 Employee stock plan registration Feb 17, 2026 —
10-K Annual report Feb 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 11, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Agreement ended
Dec 12, 2025 Dec 9, 2025
8-K Current report
Other events
Dec 5, 2025 Dec 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 20, 2025 Oct 17, 2025
8-K Current report
Other events
Sep 8, 2025 Sep 7, 2025
8-K Current report
Material agreement
Sep 2, 2025 Aug 29, 2025
S-8 Employee stock plan registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change
Jun 27, 2025 Jun 26, 2025
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 24, 2025
ARS Annual report to shareholders May 20, 2025 Dec 31, 2024
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 24, 2025
8-K Current report
Officer or director change
Apr 2, 2025 Mar 28, 2025
S-8 Employee stock plan registration Feb 18, 2025 —
10-K Annual report Feb 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 13, 2025 Feb 13, 2025
8-K Current report
Officer or director change
Feb 10, 2025 Feb 10, 2025
8-K Current report
Material agreement
Dec 30, 2024 Dec 27, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 4, 2024 Nov 4, 2024
8-K Current report
Other events
Oct 25, 2024 Oct 25, 2024
8-K Current report
Other events
Oct 4, 2024 Oct 4, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
10-Q/A Amended quarterly report Aug 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Material agreement
Jul 31, 2024 Jul 30, 2024
8-K Current report
Other events
Jul 11, 2024 Jul 9, 2024
424B5 Prospectus supplement Jul 10, 2024 —
424B5 Prospectus supplement Jul 9, 2024 —
8-K Current report
Results of operations, Other events
Jul 9, 2024 Jul 9, 2024
8-K Current report
Other events
Jul 8, 2024 Jul 8, 2024
8-K Current report
Officer or director change
Jun 27, 2024 Jun 21, 2024
8-K Current report
Other events
Jun 3, 2024 Jun 3, 2024
8-K Current report
Shareholder vote results
May 31, 2024 May 31, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 19, 2024 May 31, 2024
8-K Current report
Material agreement
Mar 12, 2024 Mar 8, 2024
S-8 Employee stock plan registration Feb 20, 2024 —
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 20, 2024 Feb 20, 2024
8-K Current report
Other events
Jan 23, 2024 Jan 22, 2024
8-K Current report
Material agreement
Jan 19, 2024 Jan 19, 2024
424B5 Prospectus supplement Jan 19, 2024 —
8-K Current report
Other events
Jan 16, 2024 Jan 12, 2024
8-K Current report
Other events
Jan 12, 2024 Jan 4, 2024
8-K Current report
Material agreement
Dec 4, 2023 Nov 29, 2023
8-K Current report
Material agreement
Nov 17, 2023 Nov 14, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Oct 27, 2023 Oct 24, 2023
424B5 Prospectus supplement Oct 26, 2023 —
424B5 Prospectus supplement Oct 24, 2023 —
8-K Current report
Results of operations, Other events
Oct 24, 2023 Oct 24, 2023
8-K Current report
Other events
Oct 23, 2023 Oct 23, 2023
8-K Current report
Officer or director change
Sep 26, 2023 Sep 21, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Officer or director change
Jul 3, 2023 Jun 29, 2023
8-K Current report
Material agreement
Jun 30, 2023 Jun 26, 2023
424B5 Prospectus supplement Jun 26, 2023 —
S-3ASR Automatic shelf registration Jun 26, 2023 —
8-K Current report
Shareholder vote results, Other events
Jun 9, 2023 Jun 6, 2023
8-K Current report
Material agreement
Jun 6, 2023 Jun 1, 2023
8-K Current report
Material agreement, Agreement ended
May 16, 2023 May 12, 2023
ARS Annual report to shareholders May 15, 2023 Dec 31, 2022
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Other events
Apr 27, 2023 Apr 24, 2023
424B5 Prospectus supplement Apr 26, 2023 —
424B5 Prospectus supplement Apr 24, 2023 —
8-K Current report
Results of operations, Other events
Apr 24, 2023 Apr 24, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 23, 2023
DEF 14A Proxy statement Apr 14, 2023 Jun 7, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 7, 2023 —
10-K Annual report Mar 7, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 7, 2023 Mar 7, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Other events
Sep 19, 2022 Sep 14, 2022
424B5 Prospectus supplement Sep 15, 2022 —
424B5 Prospectus supplement Sep 14, 2022 —
8-K Current report
Other events
Sep 14, 2022 Sep 11, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
8-K Current report
Material agreement
Jul 27, 2022 Jul 26, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 9, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEF 14A Proxy statement Apr 26, 2022 Jun 9, 2022
8-K Current report
Officer or director change
Apr 6, 2022 Apr 5, 2022
10-K Annual report Mar 18, 2022 Dec 31, 2021
S-8 Employee stock plan registration Mar 17, 2022 —
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Other events
Jul 12, 2021 Jul 7, 2021
424B5 Prospectus supplement Jul 8, 2021 —
424B5 Prospectus supplement Jul 6, 2021 —
8-K Current report
Other events
Jun 28, 2021 Jun 28, 2021
8-K Current report
Shareholder vote results
Jun 14, 2021 Jun 10, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
EFFECT Filing Apr 20, 2021 —
DEF 14A Proxy statement Apr 19, 2021 Jun 10, 2021
CORRESP Letter to the SEC Apr 16, 2021 —
UPLOAD Letter from the SEC Mar 25, 2021 —
S-8 Employee stock plan registration Mar 23, 2021 —
S-3 Shelf registration Mar 23, 2021 —
10-K Annual report Mar 23, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 23, 2021 Mar 23, 2021
SEC STAFF LETTER Filing Mar 23, 2021 —
SEC STAFF LETTER Filing Feb 23, 2021 —
8-K Current report
Officer or director change
Feb 17, 2021 Feb 12, 2021
8-K Current report
Material agreement
Jan 21, 2021 Jan 20, 2021
424B5 Prospectus supplement Jan 21, 2021 —
8-K Current report
Other events
Jan 19, 2021 Dec 7, 2020
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 12, 2020
8-K Current report
Material agreement
Sep 24, 2020 Sep 23, 2020
8-K/A Amended current report
Officer or director change
Sep 16, 2020 Jun 26, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
424B5 Prospectus supplement Aug 12, 2020 —
8-K Current report
Results of operations
Aug 12, 2020 Aug 12, 2020
8-K Current report
Unregistered share sale
Aug 4, 2020 Aug 3, 2020
8-K Current report
Officer or director change
Jun 30, 2020 Jun 26, 2020
8-K Current report
Other events
Jun 22, 2020 Jun 17, 2020
424B5 Prospectus supplement Jun 18, 2020 —
424B5 Prospectus supplement Jun 16, 2020 —
8-K Current report
Shareholder vote results
Jun 16, 2020 Jun 16, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Jun 16, 2020 Jun 15, 2020
EFFECT Filing Jun 10, 2020 —
CORRESP Letter to the SEC Jun 9, 2020 —
UPLOAD Letter from the SEC Jun 8, 2020 —
S-3 Shelf registration Jun 1, 2020 —
10-Q Quarterly report May 12, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 12, 2020 May 12, 2020
DEF 14A Proxy statement Apr 27, 2020 Jun 16, 2020
8-K Current report
Officer or director change
Apr 7, 2020 Apr 6, 2020
S-8 Employee stock plan registration Mar 24, 2020 —
10-K Annual report Mar 24, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 24, 2020 Mar 24, 2020
8-K Current report
Material agreement
Mar 17, 2020 Mar 11, 2020
8-K Current report
Material agreement
Mar 11, 2020 Mar 5, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Officer or director change
Dec 18, 2019 Dec 17, 2019
8-K Current report
Other events
Nov 20, 2019 Nov 20, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2019 Nov 13, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
8-K Current report
Material agreement, Other events
Oct 7, 2019 Sep 30, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2019 Aug 12, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
S-8 Employee stock plan registration May 28, 2019 —
8-K Current report
Bylaw or fiscal year change, Other events
May 28, 2019 May 28, 2019
CT ORDER Filing May 24, 2019 —
424B4 Prospectus May 24, 2019 —
EFFECT Filing May 22, 2019 —
CERT Filing May 22, 2019 —
S-1/A Amended registration statement May 21, 2019 —
CORRESP Letter to the SEC May 20, 2019 —
CORRESP Letter to the SEC May 20, 2019 —
S-1/A Amended registration statement May 17, 2019 —
8-A12B Filing May 17, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IDYA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1676725

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.